Access to the PDF text

Free Article !

Diabetes & Metabolism
Vol 24, N° 3  - juin 1998
p. 200
Doi : DM-06-1998-24-3-1262-3636-101019-ART50


Isolement, culture et évaluation fonctionnelle des îlots de Langerhans.



Mots clés : transplantation, îlot, homme, porc, isolement, collagénase,purification, culture, viabilité


The collagenase digestion phase of islet isolation is variable and unpredictable. Thisresults partly from the vagaries of collagenase itself but also from the complex effectsof organ retreival and storage on collagenase digestion. Improvements in the purificationof islets by density gradient centrifugation will not result from the production of newdensity gradient media, but rather from the continued modification of the biochemicalcomposition of the solvents in which established gradient media are dissolved. Thechallenge is to produce solutions that will minimise acinar tissue swelling withoutcompromising islet yield and viability. It is sobering to note the low recovery of isletsafter 48-h tissue culture (56 %), and it has to be concluded that present tissueculture techniques for human and porcine islets are inadequate. Part of the problem isthat the media and techniques used for islet tissue culture were designed for single cellculture and were not formulated specifically for the culture of insulin-producingmini-organs with a high metabolic rate. Cell viability is notoriously difficult toquantify, and this is no less true for isolated islets than for other tissues. The mainproblem is that although it is possible to determine the viability of isolated islets bymeasuring specific cellular functions such as glucose-stimulated insulin release, it isimpossible to compare this with the same function performed by islets within the nativepancreas. For this reason, it is not possible in absolute terms to determine the effect ofislet isolation on islet viability.

Key-words : islet transplantation, human, porcine, isolation, collagenase,purification, tissue culture, viability.

L'étape de digestion par la collagénase de l'isolement d'îlots est variable etimprévisible, du fait d'une part de la variabilité de la collagénase mais aussi deseffets complexes du prélèvement et du stockage du pancréas sur la digestion par lacollagénase. L'amélioration de la purification des îlots par la centrifugation surgradient ne résultera pas de la mise au point de nouveaux milieux pour le gradient dedensité, mais plutôt de modifications de la composition biochimique des solvants danslesquels sont dissous les milieux de gradient. Il conviendrait de produire des solutionsqui minimiseront la désintégration du tissus exocrine sans compromettre le rendement etla viabilité des îlots. En constatant la faible récupération d'îlots après48 heures de culture (56 %), on peut en conclure que les techniques de cultureactuelles des îlots humains et porcins sont imparfaites. Cela résulte en partie du faitque ces techniques actuelles ont été conçues pour des cultures de cellules isolées etpas pour celles de mini-organes insulinosecréteurs dont le métabolisme est élevé. Laviabilité cellulaire est notoirement difficile à quantifier aussi bien pour des îlotsisolés que pour d'autres tissus. Le principal problème est que, bien qu'il soit possiblede mesurer la fonction insulaire par l'insulinosecrétion stimulée par le glucose, il estimpossible de la comparer à la fonction des îlots au sein du pancréas entier. Pourcette raison, il n'est pas possible de déterminer, en valeur absolue, l'effet del'isolement d'îlots sur la viabilité insulaire.

mots-clés :

N.J.M. London, Department of Surgery, Clinical Sciences Building,Leicester Royal Infirmary, Leicester LE2 7LX, UK. Tel : 01162 523252. Fax :01162 523179.

lthough there is a wealth of experimental data concerning the isolation, culture andfunctional evaluation of rodent and small animal islets of Langerhans, much of thisinformation has not proven directly applicable to the large animal and human situation.This review will therefore focus on the problems posed by human and pig islet isolation,the former because human islet isolation is already a clinical reality, the latter becausepig islets are likliest to be used first for clinical xenotransplantation.


Islet isolation is critically affected by all stages that precede it, and this isparticularly true for the human pancreas. Warm ischaemia is especially [1] damaging andshould be avoided at all costs ; similarly, cold [2] ischaemia should be minimised.


vascular perfusion is now an integral part of the organ donation operation inmany countries ; and, although vascular perfusion impairs porcine islet isolation[3], a prospective randomised study from Edmonton has shown for human islet isolation thatvascular perfusion with University of Wisconsin (UW) solution does not reducepost-purification islet yields as compared to no perfusion at all [4]. The question ofwhich vascular perfusate to use for the human pancreas has not been the subject ofprospective studies. However, EuroCollins solution appears to be detrimental to humanislet isolation [5] and is certainly not an effective vascular flush solution if coldischaemic time is greater than 6 h [6]. Although UW solution appears to providereasonable pancreas preservation for up to 18 h [7] prior to human islet isolation(based on International Islet Transplant Registry data [8]), it would seem inadvisable totransplant islets isolated from UW-perfused human pancreata with a cold ischaemic time ofmore than 12 h.

Intraductal distention with collagenase suspended in UW solution immediately afterpancreas excision allows effective storage of the pig [9] pancreas for up to 24 hprior to islet isolation. Unfortunately, this approach has provided very poor islet yieldsand viability in the human for both stored and non-stored pancreata [10], probably becauseUW solution contains inhibitors of collagenase [11] and is toxic to human tissues at37Ý C [12]. The challenge in the human therefore is to develop UW-based cold storagesolutions that optimise preservation when given intraductally but do not compromise isletyield or viability. It is convenient to subdivide the process of islet isolation intopancreas dissociation and islet purification.

Pancreas dissociation -

Current methods for human and pigpancreas dissociation are based on the principles described by Gray

et al.

[13] in1984. The technique consisted of the intraductal administration of collagenase [14],followed by incubation at 39Ý C, with gentle teasing and shaking, and then triturationthrough wide-bore needles. Although improvements in this manual method have been described[15], the description of an automated method by Ricordi

et al.

[16] is generallyagreed to represent a significant advance. Indeed, porcine studies [17] that have comparedmanual with automated methods have shown significantly increased islet yields (three timesas many IEQ) with the automated method. The principles behind the automated method areminimal physical trauma and continuous collagenase digestion of the pancreas during whichislets are continually removed from the injurious action of collagenase [18].

Regardless of the technique used, the collagenase digestion phase is criticallydependent upon the efficiency of the collagenase. A good enzyme will release intact isletsthat are entirely free of exocrine tissue (cleaved). Unfortunately, batch-to-batchvariation and deterioration of a good batch with storage are a common experience. Indeed,the vicissitudes of collagenase [19-21] have driven many investigators to despair, and fewwould disagree with Scharp [22] that collagenase is one of the major obstacles tosuccessful human islet transplantation. Crude collagenase is derived from cultures of


and may contain up to 11 different collagenases, each with differentspecificities towards different collagens [23]. In addition, crude collagenase containsnumerous other enzymes [21]. Highly purified collagenase is ineffective for isletisolation [24], and some of the other components of crude collagenase are thereforenecessary. Recent rat studies have investigated the role of the various types ofcollagenase present in crude collagenase on islet isolation and have shown that pancreasdissociation can be manipulated by using defined mixtures of collagenases. These studiesneed to be repeated in the human because it has been shown that there is a marked speciesvariation in both total pancreatic collagen content [25] and collagen type anddistribution [26]. Thus, unfortunately, a collagenase batch that works well in the pig ordog may not work in the human. The recent development of a collagenase blend called"Liberase" may represent an advance [27] ; prospective randomised trialsare however still awaited.

The efficiency of the collagenase digestion phase may be affected by a number offactors in addition to the collagenase batch. The pancreas should be uniformly distendedbecause islets are not isolated from undistended segments [28]. The question as to whetherthe collagenase solution should be perfused or loaded into the pancreatic duct has beeninvestigated by Warnock

et al.

[6] who showed, although not conclusively, that theductal perfusion technique improved islet yields. A further issue is the optimum timing ofcollagenase injection. There is inevitably a period of cold storage between pancreasexcision and the commencement of islet isolation. Ohzato

et al.

[29] have shown inthe rat that cold storage leads to loss of ductal integrity, so that during ductaldistention the pressures achieved were lower, pancreas distention was suboptimal, andcollagenase was more likely to enter the islets themselves. It was also shown that theyields of rat islets were increased if collagenase was given intraductally in Hanks'balanced salt solution (HBSS) at the time of pancreas excision prior to cold storage for4 or 6 h. It has subsequently been shown that for young human organ donors(< 30 yr) intraductal injection of collagenase in HBSS prior to, rather thanafter, 3-h cold ischaemia, significantly improves islet yields [30]. It has however beenshown for donors of all ages that immediate intraductal injection of collagenase improvesislet survival in low temperature culture.

It can be deduced from the foregoing discussion that the collagenase digestion phase ofhuman islet isolation remains variable and unpredictable. Indeed, it has been shown thatthe proportion of pancreatic insulin recovered in the pancreatic digest after collagenasedispersion of the human pancreas ranges from 7 to 91 % [15]. Much of thisvariability relates to the effects of cold storage and the vagaries of collagenase itself,and these issues must be considered as research priorities.

Purification -

Although a large number of islet purificationtechniques, including differential sedimentation at unit gravity [31], filtration [32],the use of Velcro to remove acinar tissue [33], centrifugal elutriation [34],cryopreservation [35], gamma irradiation [36], anti-acinar cytotoxic antibodies [37],tissue culture [38], the selective destruction of acinar cells by laser energy [39] orhypotonic lysis [40], magnetic microspheres coated with anti-acinar cell monoclonalantibodies [41], and fluorescence-activated cell sorting [42] have been used in otherspecies, density gradient centrifugation is the only technique that has been successfullyused for large-scale porcine and human islet purification. The technical aspects of thediscussion will therefore focus on density gradient purification. Human islet purificationhas proven particularly difficult because both the density and the diameter of acinartissue, and to a lesser extent of islets, changes from one preparation to another [43].Islets normally vary in diameter from 15-500 µm and, in addition, the diameter ofislets and acinar tissue is critically dependent upon the collagenase digestion stage ofthe isolation process. This intrinsic variation in islet diameter, combined with theeffect of collagenase digestion, means that we have no control over endocrine and acinartissue size distribution. Because of these highly variable and overlapping tissuediameters, it is not possible to purify islets from acinar tissue using velocitysedimentation, and we are forced to use isopycnic centrifugation.

There are a number of possible causes for variable acinar tissue density. First, it ispossible that acinar tissue density depends on the secretory status of the acinar cells.Second, the density of acinar cells may be affected by the size of the aggregates formed[44] by the collagenase digestion of the pancreas, and finally, acinar tissue density maybe reduced by cellular swelling and oedema. Recent studies [45] have shown that the singlemost important factor affecting the density of acinar tissue during islet isolation isacinar tissue swelling and oedema, acinar tissue degranulation being relativelyunimportant. Acinar cell swelling can be provoked by a number of insults, includingmechanical trauma [46] and hypothermia, and collagenase digestion has been shown toinfluence cell membrane permeability and to cause cell swelling [47].

Broadly speaking, techniques for optimising density gradient purification can bedivided into physical and chemical ones. We will first consider physical parameters. Forcell separation to be optimised, it is essential that certain experimental conditions becontrolled. Temperature may affect the results of density gradient purification [48], andit has been shown that the results of human islet purification using BSA are the same at 4ÝC and 22 ÝC, whereas porcine islet purification is more efficient at 4 ÝC [49].Continuous gradients offer many theoretical advantages over discontinuous gradients [50],and it has been demonstrated that large-scale continuous density gradients can beestablished on the COBE 2991 processor [51, 52]. This therefore is the preferredtechnique for large-scale human islet purification. It has been shown that, compared todiscontinuous gradients on the COBE 2991, continuous gradients improve human islet yieldby 26 % and also improve islet viability.

Chemical methods for improving the purification of human islets by isopycniccentrifugation aim to increase or maintain acinar tissue density whilst leaving isletdensity relatively unaltered. One approach has been described by van der Burg

et al.

[53] who greatly improved the results of canine islet purification by collecting andwashing the pancreatic digest in UW solution prior to density gradient centrifugation.These findings have been confirmed in the human [54], and for some isolations the resultsof density gradient purification are further improved by storing the digest in UW solution(at 4 ÝC) for 1 h prior to centrifugation. The beneficial action of UW storageresults largely from the presence of the extracellular impermeant anion lactobionate [45]and the colloid hydroxyethyl starch [55].

The most commonly used gradient media for human islet isolation are Ficoll [6],Euroficoll [56], Ficoll-Diatrizoic acid [1] and hyperosmolar bovine serum albumin (BSA)[57, 58]. Further improvements in the purification of islets by density gradientcentrifugation will not result from the production of new density gradient media, butrather from the continued modification of the biochemical composition of the solvents inwhich established gradient media are dissolved. These modifications may however produce anunphysiological environment [59], and consequently their effect on islet viability must bedetermined. In the human, the challenge is to produce solutions that will minimise acinartissue swelling without compromising islet yield and viability. It has been shown thathyperosmolar BSA density gradients improve human [43] (500 mOsm/kg/H


O)and porcine [49] (400 mOsm/kg/H


O) islet purification. This phenomenon hasbeen reported for other cell types [60] and in the case of islet purification results fromthe hypertonic environment


increasing the density of acinar tissuemore than endocrine tissue [61]. A further promising approach to minimise acinar tissueswelling is the construction of density gradients by the addition of extra hydroxyethylstarch or Percoll to University of Wisconsin solution [62].


The culture of islets poses several unique problems. First, due to the size of theislets, the central core can become necrotic, probably as a result of inadequate oxygensupply. Second, unlike many single cell types, islets do not proliferate in culture, andthis makes the assessment and comparison of different culture techniques difficult.Usually, the proliferation rate of a cell line is the determinant of the effect of achange in the culture medium composition. Finally, islets from different species may haveunique requirements or behaviour in tissue culture. For example, pig islets tend tofragment very easily in culture, probably due to the lack of a defined capsule [63].

It is pertinent to begin by asking "is it necessary to culture islets ?"First, there is the need to store islets prior to transplantation. Second, a period of lowtemperature may be used to immunomodulate islets to abrogate rejection of the transplantedtissue. Third, Weber

et al.

[64] have demonstrated that a period in culture can beused to purify islet preparations. Although there are many positive reasons for culturingislets, the potential risk of infection should also be considered. One recent report hashighlighted the problem of infected islets leading to episodes of bacteremia in islettransplant patients [65]. Although the source of this infection was determined to becryopreserved islets, it is apparent that any increase in the number of proceduresundertaken on islets will increase the risk of infection occurring. Other reportsassessing the sterility of islet preparations or the incidence of infection in patientsfollowing islet transplantation have tended to demonstrate factors other than the cultureof islets as having the greatest risk. For example, Scharp

et al.

[66] found thatthe greatest infection source was from the pancreas transport fluid, whilst the Ficolldensity gradient medium was the major source of contamination introduced duringprocessing.

Commercially available media -

One of the earliest studiescomparing the culture of islets in different commercially available media was undertakenusing rat islets in 1978 by Andersson [67]. The study compared the effectiveness of TCM199, RPMI 1640, CMRL 1066, MEM and Ham's F10. The results demonstrated that the islets inF10 had the highest insulin content, but that the highest insulin biosynthesis ratewas in the islets cultured in RPMI. Andersson therefore concluded that RPMI was the mediumof choice for islets, possibly due to the nicotinamide content and the 11mM glucoseconcentration. Davalli

et al.

[68] reported the results of culturing porcine isletsin CMRL 1066, RPMI 1640 without glucose, RPMI 1640 with 11mM glucose, Ham'sF12 or TCM 199. All the media were supplemented with 10 % FCS, and the isletswere tested by insulin release. Only TCM 199 gave an increase in glucose-stimulatedinsulin release, whilst islets cultured in either CMRL or RPMI (both with or withoutglucose) showed a decrease in release. The authors commented that TCM 199 is the onlyone of these media which contains adenosine phosphates and xanthine, and that these couldtherefore be of importance in islet culture. They also suggested that the relatively highglucose concentrations of Ham's F12 (9.9mM) and RPMI could be toxic to the islets.

The results of the above studies suggest that islets isolated from different speciesmay have different requirements in culture. This is supported by the results of Holmes


[69] who cultured rat, porcine and human islets for a week in ten differentcommercially available media, providing a more comprehensive comparison than hadpreviously been undertaken. They concluded that Iscove's MEM was the best medium for ratislets, Ham's F12 nutrient mixture was best for porcine islets, and CMRL1066 was best for human islets. These results do not concur with the above studies,although this could be due to Iscove's medium not having been previously tested. Moreover,the length of time the islets were in culture was greater than that used for porcineislets by Davalli

et al.

[68] (48 h compared with a week), which could haveaffected the results. A recent report from Rastellini

et al.

[70] examined theeffect of adding pyruvate (7mM) to CMRL-1066 on the viability of cultured humanislets. After 60 days in culture, 67 % of pyruvate-cultured islets could berecovered compared to 0 % in the control group. This promising approach certainlymerits further investigation.

Serum-free media -

Foetal calf serum (FCS) or newborn calfserum (NBCS) is routinely added to culture medium for a wide range of cells and tissues.The reason for this is because the serum contains many components which are beneficial forcell survival and growth. Unfortunately, however, there can be a considerable variationbetween batches of serum, some of which may even be toxic to islets. Much of the workundertaken on the effect of serum on islet culture has assessed whether it is possible forislets to survive without the presence of serum if other constituents are added to themedium. A major reason for trying to omit serum from islet culture medium is to move awayfrom the use of animal products when tissue is to be used for human transplantation. Tai


[71] undertook a study on porcine islets, assessing the use of serum replacementproducts. They found that they were not suitable for long-term culture and suggested thatthis could partially be due to variation between batches of these products. These studiesdemonstrate that more developmental work is required before islets can be routinelycultured in serum-free medium.

Oxygenation -


et al.

[72] assessed the effect ofoxygen concentrations on insulin release from canine islets, comparing normoxia(142 mmHg) with a range of hypoxic conditions (minimum of 5 mmHg). They foundthat the second phase of insulin release was decreased due to hypoxia. The authorscommented that this was thought to be due to pO


gradients outside and insidethe islets. This results in the islets being exposed to low pO


decreasingradially from the periphery to the core, possibly leading to depletion of the energystores from the beta cells. It has been shown that liver cells are in oxygen debt within afew hours of establishing a primary culture if the medium is 3 mm deep. It isprobable that such an effect would occur with islets under similar circumstances, and thishighlights the speed at which less than optimal culture conditions can affect theviability of the tissue. It is clear, therefore, that methods of improving oxygen supplyto the islets in culture, and diffusion into the centre of the islets, are required. Onefactor, already highlighted above, is the depth of the medium. This should be kept to aminimum to allow rapid diffusion of oxygen to the islets, and a depth of 2 mm hasbeen recommended for cells with a high oxygen requirement.

Alternative methods may include the addition of oxygen carriers to the medium,constantly bubbling oxygen through the medium, a rolling culture system, or a stirredculture system in which the islets are maintained in suspension by a magnetic stirring barsuspended from the top of the bottle. The potential problem with any system designed tokeep the islets constantly moving is the fragility of the islets, especially porcineislets. Tests would be required to determine whether this type of culture system issuitable for islets, and whether it can be applied to all species of islets.

The role of exocrine tissue -

A study undertaken by Metrakos


[73] assessed the effect of interactions between different cell types on thesurvival of islets

in vitro

. After preparing ductal tissue from the pancreas andsetting up cultures of the islets together with the ducts, they found an increase inproliferation of beta cells in the presence of the ducts compared with the culture ofislets on their own. They concluded that there is an interaction between the ducts and theislets, and that this leads to an increase in proliferation, possibly as a result of therelease of factors from the ductal tissue.

Culture temperature -

Culture temperature has been investigatedwith respect to its effect both on islet immunomodulation and recovery. In 1991, Lacy andFinke [74] reported their findings on the effect of culturing rat islets at 24 ÝC ratherthan at 37 ÝC which had been the standard culture temperature. They found that at thelower temperature they achieved almost complete removal of the intraislet lymphoid cells,as long as CMRL 1066 was used as the culture medium. When RPMI 1640 was used,there was a considerable reduction in the number of lymphoid cells remaining, althoughthere were still residual cells detectable. Interestingly, RPMI was originally developedfor the culture of lymphocytes [75], whereas CMRL 1066 was originally developed forthe culture of fibroblasts and kidney epithelial cells [75]. Recently, Dabbs

et al.

[76] have shown that 7-day low-temperature (24 ÝC) culture can slightly prolong isletallograft survival in CsA-treated dogs.


et al.

[77] assessed human islet recovery after 24-h culture as part of astudy on cryopreserved islets. They reported a mean recovery rate of 72.5 % forislets cultured at 22 ÝC compared with 54.8 % at 37 ÝC. This study indicates aconsiderable benefit for islets cultured at 22 ÝC as compared to 37 ÝC.

Culture matrix -

One factor which also needs consideration iswhether islets should be cultured in a three-dimensional matrix or be maintained as afree-floating culture. Ohgawara

et al.

[78] cultured foetal porcine pancreas in acollagen gel matrix. They found that nicotinamide had to be added to the culture toprevent the degradation of the collagen gel. However, the authors noted that thenicotinamide had the added benefit of preventing the growth of fibroblast like cells.Brendel

et al.

[79] compared the culture of human islets in standard suspensionculture and in matrices of either agarose or alginate. They found that the number ofislets surviving over the period of study was greater when the matrices were used, andthat agarose provided better results compared with alginate. The insulin release resultswere also better in agarose, although the ratio of total insulin release to total DNA wasnot significantly different between the groups. All the islets had good perifusionresponses, but the best transplantation results were obtained with the islets which hadbeen cultured in the agarose matrix. The authors commented the ease with which the isletscould be retrieved from the gel when they were required for transplantation, a problemwhich can result in the loss of a lot of islets when other matrices are used.The two majorproblems associated with the culture of islets in three-dimensional matrices are the lossof islet tissue when they are retrieved from the matrix, and the diffusion of nutrientsand waste products across the matrix. The latter study suggests that these problems mayhave been overcome. If this is the case, this system of culture may be of use for routineculture of islets. However, before this can happen, the other aspects of the isletphysiology and viability require study, for example, the supply of oxygen to the islet andthe problems of central necrosis.

Although they did not use matrices for islet culture, Hober

et al.

[80] assessedthe use of wellplates with inserts for the culture of islets. They found that the insertsdid not allow cell attachment and therefore prevented fibroblast growth. The isletsmaintained good three-dimensional form and good viability. The authors also listed severaladvantages of this system : the endocrine tissue was of high purity ; it waseasier to change the medium ; they could perform tests by moving just the inserts,preventing the loss of any islets ; and the collection of islets was improved withoutcausing them any damage.

Conclusions -

The media currently used for islet culture wereoriginally designed for proliferating cell lines and were not specifically designed forthe culture of highly specialised metabolically active "mini-organelles". Theoptimum conditions for islet culture need to be determined, both in terms of the nutrientsutilised by the cells and the ability to ensure their supply to core cells at the centreof the islets. Furthermore, the results of published studies suggest that the culturerequirements of islets may be species-specific, and new media must be developed with thisin mind. In conclusion, at the present time islets are cultured in ‘adopted'media, and there is clearly an urgent need to develop specific culture media for islets ofLangerhans. Only then will islet culture be by design rather than by proxy !


Islet viability may be adversely affected by innumerable factors including eventsoccurring before and during organ donation, during the period of cold ischaemia prior toislet isolation, the isolation process itself, and the period of storage (tissue cultureand/or cryopreservation) prior to transplantation. After transplantation, islet viabilitymay suffer due to impaired revascularisation or the action of islet-toxic substances. Allof these factors will of course increase the number of islets required to producenormoglycaemia. The impact of impaired islet viability on the outcome of human islettransplantation can be deduced from the observation that in the period 1990-1992 no isletpreparations prepared from pancreata with a cold ischaemic time greater than 12 hproduced insulin independence [8].

Unfortunately, cell viability is notoriously difficult to quantify [81], and this is noless true for isolated islets than for other tissues. The main problems are that, althoughit is possible to determine the viability of isolated islets by measuring specificcellular functions (e.g. glucose-stimulated insulin release), it is impossible to comparethis with the same function performed by islets within the native pancreas, so thatinsulin release reflects the function of only a single metabolic pathway within islets andchanges in insulin secretion in response to alterations in glucose concentration may notreflect changes in global islet function or viability. For these reasons, it is notpossible in absolute terms to determine the effect of islet isolation on islet viability.It is possible however to estimate the effect of various procedures (e.g. differentdensity gradient media or cryopreservation) on the viability of islets after isolation.The

in vitro

methods available include light [82] and electron microscopicmorphology [83], fluorometric membrane integrity assays [84-87], colorimetric tests ofmitochondrial function [88, 89] and glucose-stimulated insulin release [90, 91]. Theresults of islet perifusions should be interpreted with caution. Thus, cryopreservedcanine islets that failed to secrete insulin during perifusion consistently inducednormoglycaemia after autotransplantation [92], and it has been reported that a poorresponse from human islets during perifusion did not predict their

in vivo

functionafter transplantation [93]. Undoubtedly, the best index of viability is the ability oftransplanted islets to reverse diabetes [94], which in the case of human islets can beachieved by transplantation into the diabetic immunodeficient mouse [95, 96] or rat [97].The problems with these latter methods are the difficulties of maintaining immunodeficientrodents and that, although reversal of diabetes shows that the islets are viable, it doesnot show



In summary, although islet viability is a critical factor that determines the outcomeafter transplantation, there is no currently available method for standardising viabilityassessment. It would however seem sensible to at least confirm that human islets are notdead prior to transplantation, and membrane integrity assays or perifusions are the mostconvenient way of doing this at the present time.

© Masson, Paris, 1998 Brandhorst H, Klitscher D, Hering BJ, Federlin K, Bretzel RG. Influence of organprocurement on human islet isolation. Horm Metab Res, 1993, 25, 51-52.

Top of the page

Kneteman NM, Lakey JRT, Warnock GL, Rajotte RV. Pancreas procurement andpreservation : impact on islet recovery and viability. In : Ricordi C, ed.« Pancreatic islet cell transplantation. 1892-1992. One century of transplantationfor diabetes +. Austin, Georgetown : R.G. Landes company, 1992, 72.
Ricordi C, Socci C, Davalli AM et al . Effect of pancreas retrieval procedure onislet isolation in the swine. Transplant Proc, 1990, 22 (2), 442-443.
Kneteman NM, Lakey JR, Kizilisik TA, Ao Z, Warnock GL, Rajotte RV. Cadaver pancreasrecovery technique. Impact on islet recovery and in vitro function. Transplantation, 1994, 58, 1114-1119.
Kneteman NM, DeGroot TJ, Warnock GL, Rajotte RV. The evaluation of solutions for pancreaspreservation prior to islet isolation. Horm Metab Res Suppl, 1990, 25, 4-9.
Warnock GL, Ellis D, Rajotte RV, Dawidson I, Baekkeskov S, Egebjerg J. Studies of theisolation and viability of human islets of Langerhans. Transplantation, 1988, 45, 957-963.
Kneteman NM, Lakey JRT, Warnock GL, Rajotte RV. Human islet isolation after prolonged coldstorage. Diab Nutr Metab, 1992, 5 (Suppl 1), 33-37.
Federlin K, Bretzel RG, Hering BJ. International Islet Transplant Registry. NewsletterNo 4, 1993, 3 .
Mellert J, Hering BJ, Hopt UT et al . Exchange of pancreata and islets betweencenters for experimental islet transplantation in the pig. Transplant Proc, 1991, 23, 2435-2436.
Casanova D, Xenos E, Lloveras JJ et al . Comparison of human islet isolation fromthe stored and nonstored pancreas with two different protocols using UW solution. TransplantProc, 1994, 26, 588.
Seifter S, Harper E. Collagenases. In : Colowick SP, ed. « Methods enzymol(Volume 19) +. New York : Academic Press, 1970, 613.
Belzer FO. Correct use of University of Wisconsin preservation solution. Lancet, 1990, 335, 362.
Gray DW, McShane P, Grant A, Morris PJ. A method for isolation of islets of Langerhansfrom the human pancreas. Diabetes, 1984, 33, 1055-1061.
Horaguchi A, Merrell RC. Preparation of viable islet cells from dogs by a new method. Diabetes, 1981, 30, 455-458.
London NJM, Lake SP, Wilson J et al . A simple method for the controlled collagenasedigestion of the human pancreas. Transplantation, 1990, 49, 1109-1113.
Ricordi C, Lacy PE, Scharp DW. Automated islet isolation from human pancreas. Diabetes, 1989, 38 (Suppl 1), 140-142.
Toomey P, Chadwick DR, Contractor H, Bell PRF, James RFL, London NJM. Porcine isletisolation : prospective comparison of automated and manual methods of pancreaticcollagenase digestion. Br J Surg, 1993, 80, 240-243.
Ricordi C, Lacy PE, Finke EH, Olack BJ, Scharp DW. Automated method for isolation of humanpancreatic islets. Diabetes, 1988, 37, 413-420.
Scharp DW. The elusive human islet : Variables involved in its effective recovery.In : van Schilfgaarde R, Hardy MA, eds. « Transplantation of the endocrinepancreas in diabetes mellitus +. Amsterdam : Elsevier, 1988, 97.
Gray DWR, Leow CK. Non-automated methods for islet isolation. In : Ricordi C, ed.« Pancreatic islet cell transplantation.1892-1992. One century of transplantationfor diabetes +. Austin : R.G.Landes, 1992, 89.
Wolters GH, van Suylichem PT, van Deijnen JH, van Schilfgaarde R. Factors influencing theisolation process of islets of Langerhans. Horm Metab Res Suppl, 1990, 25, 20-26.
Scharp DW. Commentary. Cell Transplantation, 1993, 2, 299.
Soru E, Zaharia O. Clostridium Histolyticum collagenase II. Partial characterisation .Enzymologia, 1972, 43, 45-55.
Traverso LW, Abou-Zamzam AM. Activation of pancreatic proteolytic enzymes by commercialcollagenases. Transplantation, 1978, 25, 226-227.
van Suylichem PT, Pasma A, Wolters GH, van Schilfgaarde R. Microscopic aspects of thestructure and collagen content of the pancreas from the perspective of islet isolation. TransplantProc, 1987, 19, 3958-3959.
van Deijnen JH, Hulstaert CE, Wolters GH, van Schilfgaarde R. Significance of theperi-insular extracellular matrix for islet isolation from the pancreas of rat, dog, pig,and man. Cell Tissue Res, 1992, 267, 139-146.
Linetsky E, Bottino R, Lehmann R, Alejandro R, Inverardi L, Ricordi C. Improved humanislet isolation using a new enzyme blend, Liberase. Diabetes, 1997, 46, 1120-1123.
Gotoh M, Ohzato H, Porter J, Maki T, Monaco AP. Crucial role of pancreatic ductalcollagenase injection for isolation of pancreatic islets. Horm Metab Res Suppl, 1990, 25, 10-16.
Ohzato H, Gotoh M, Monden M, Dono K, Kanai T, Mori T. Improvement in islet yield from acold-preserved pancreas by pancreatic ductal collagenase distention at the time ofharvesting. Transplantation, 1991, 51, 566-570.
Socci C, Davalli AM, Vignali A et al . A significant increase of islet yield byearly injection of collagenase into the pancreatic duct of young donors. Transplantation, 1993, 55, 661-663.
Dobroschke J, Langhoff G, Seyed Ali S, Kunze HH, Schwemmle K. Isolation of human islets ofLangerhans. In : Federlin K, Bretzel RG, eds. « Islet isolation, culture andcryopreservation +. New York : Thieme-Stratton Inc, 1981, 32.
Lorenz D, Wolff H, Lippert H, Hahn HJ, Abri O, Zander E. Clinical experience in islettransplantation. In : Thiede A, Deltz E, Engemann R, Hamelmann H, eds.« Microsurgical models in rats for transplantation research +.Berlin-Heidelberg : Springer Verlag, 1985, 359.
Kuhn F, Schulz HJ, Lorenz D et al . Morphological investigations in human islets ofLangerhans isolated by the Velcro-technic. Biomed Biochim Acta, 1985, 44, 149-153.
Scharp D, Lacy P, Ricordi C et al . Human islet transplantation in patients withtype I diabetes. Transplant Proc, 1989, 21, 2744-2745.
Evans MG, Rajotte RV, Warnock GL, Procyshyn AW. Cryopreservation purifies caninepancreatic microfragments. Transplant Proc, 1987, 19, 3471-3477.
Nason RW, Rajotte RV, Procyshyn AW, Pedersen JE. Purification of canine pancreatic isletcell grafts with radiation. Transplant Proc, 1986, 18, 174-181.
Soon-Shiong P, Heintz R, Terasaki P. An immunological method of islet cell purificationusing anti-acinar cell monoclonal antibodies. Transplant Proc, 1988, 20, 61-63.
Matas AJ, Sutherland DER, Kretschmer G. Pancreatic tissue culture : depletion ofexocrine enzymes and purification of islets for transplantation. Transplant Proc, 1977, 9, 337-339.
Brunicardi FC, Suh E, Kleinman R et al . Selective photodynamic laser treatment ofdispersed pancreatic tissue for islet isolation. Transplant Proc, 1992, 24, 2796-2797.
Liu C, McGann LE, Gao D, Haag BW, Critser JK. Osmotic separation of pancreatic exocrinecells from crude islet cell preparations. Cell Transplantation, 1996, 5, 31-39.
Fujioka T, Terasaki PI, Heintz R et al . Rapid purification of islets using magneticmicrospheres coated with anti-acinar cell monoclonal antibodies. Transplantation, 1990, 49, 404-407.
Jiao L, Gray DW, Gohde W, Flynn GJ, Morris PJ. In vitro staining of islets of Langerhansfor fluorescence-activated cell sorting. Transplantation, 1991, 52, 450-452.
London NJM, Toomey P, Contractor H, Thirdborough ST, James RFL, Bell PRF. The effect ofosmolality and glucose concentration on the purity of human islet isolates. TransplantProc, 1992, 24, 1002.
Pretlow TG, Weir EE, Zettergren JG. Problems connected with the separation of differentkinds of cells. Int Rev Exp Pathol, 1975, 14, 91-204.
Chadwick DR, Robertson GSM, Rose S et al . Storage of porcine pancreatic digestprior to islet purification : the benefits of UW solution and the role of itsindividual components. Transplantation, 1993, 56, 288-293.
Schwartz BD, Traverso LW. Morphological changes in pancreatic fragments prepared fortransplantation by collagenase treatment. Transplantation, 1984, 38, 273-280.
Burg MB, Grollman EF, Orloff J. Sodium and potassium flux of separated renal tubules. AmJ Physiol, 1964, 206, 483-491.
Legge DG, Shortman K. The effect of pH on the volume, density and shape of erythrocytesand thymic lymphocytes. Br J Haemotol, 1968, 14, 321-333.
Chadwick DR, Robertson GSM, Toomey P et al. Pancreatic islet purification usingbovine serum albumin : the importance of density gradient temperature and osmolality. Cell Transplantation, 1993, 2, 355-361.
de Duve C. Tissue fractionation, past and present. J Cell Biol, 1971, 50, 20d-55d.
Robertson GSM, Chadwick DR, Contractor H, James RFL, London NJM. The optimization oflarge-scale density gradient human islet isolation. Acta Diabetologica, 1993, 30, 93-98.
London NJM, Robertson GSM, Chadwick DR et al . Purification of human pancreaticislets by large scale continuous density gradient centrifugation. Horm Metab Res, 1993, 25, 61.
van der Burg MP, Guicherit OR, Frolich M, Prins FA, Bruijn JA, Gooszen HG. Cellpreservation in University of Wisconsin solution during isolation of canine islets ofLangerhans. Cell Transplantation, 1994, 3, 315-324.
Robertson GSM, Chadwick D, Contractor H et al . Storage of human pancreatic digestin University of Wisconsin solution significantly improves subsequent islet purification. BrJ Surg, 1992, 79, 899-902.
Robertson GSM, Chadwick DR, Davies J et al . The effectiveness of components ofUniversity of Wisconsin solution in improving human pancreatic islet purification. Transplantation, 1994, 57, 346-354.
Olack B, Swanson C, McLear M. Islet purification using Euro-Ficoll gradients. TransplantProc, 1991, 23, 774-776.
Lake SP, Bassett PD, Larkins A et al . Large-scale purification of human isletsutilizing discontinuous albumin gradient on IBM 2991 cell separator. Diabetes, 1989, 38 (Suppl 1), 143-145.
Vives M, Sarri Y, Conget I et al . Human islet function after automatic isolationand bovine serum albumin gradient purification. Transplantation, 1992, 53, 243-245.
Leif RC. Buoyant density separation of cells. In : Weid GL, Bahr GF, eds.« Automated cell identification and cell sorting +. New York : Academic Press, 1970, 21.
Boyum A. Isolation of human blood monocytes with Nycodenz, a new non-ionic iodinatedgradient medium. Scand J Immunol, 1983, 17, 429-436.
London NJM, Chadwick DR, Johnson PRV, White S, Robertson GSM. Approaches to isletpurification. In : Lanza RP, Chick WL, eds. « Pancreatic IsletTransplantation : Volume 1. Procurement of Pancreatic Islets +. Austin : R.G.Landes, 1994, 25.
Arbet-Engels C, Darquy S, Capron F, Reach G. Isolation of islets of Langerhans from therat and pig pancreas using a modified UW solution from organ storage to isletpurification. Diabete et Metabolisme, 1993, 19, 590-596.
Yamaguchi T, Mullen Y, Watanabe Y, Nomura Y, Cass D, Brunicardi C. Isolation and functionof islets from young adult pig pancreas. Transplant Proc, 1992, 24, 1010-1012.
Weber CJ, Hardy MA, Lerner RL, Reemtsma K. Tissue culture isolation and preservation ofhuman cadaveric pancreatic islets. Surgery, 1977, 81, 270-273.
Taylor GD, Kirkland T, Lakey J, Rajotte R, Warnock GL. Bacteremia due to transplantationof contaminated cryopreserved pancreatic islets. Cell Transplantation, 1994, 3, 103-106.
Scharp DW, Lacy PE, McLear M, Longwith J, Olack B. The bioburden of 590 consecutivehuman pancreata for islet transplant research. Transplant Proc, 1992, 24, 974-975.
Andersson A. Isolated mouse pancreatic islets in culture : Effects of serum anddifferent culture media on the insulin production of the islets. Diabetologia, 1978, 14, 397-404.
Davalli AM, Bertuzzi F, Socci C et al . In vitro function of adult pig islets :effect of culture in different media. Transplant Proc, 1992, 24, 2794-2795.
Holmes MA, Clayton HA, Chadwick DR, Bell PRF, London NJM, James RFL. Functional studies ofrat, porcine, and human pancreatic islets cultured in ten commercially available media. Transplantation, 1995, 60, 854-860.
Rastellini C, Cicalese L, Zeevi A et al. Long-term culture of viable humanpancreatic islets in pyruvate-rich medium. Transplant Proc, 1995, 27 (6),3383-3384.
Tai J, Tsang A, Tze WJ. Effects of serum and medium supplements, pH and temperature on theviability of cultured porcine islets. Transplant Proc, 1994, 26 (2),818-819.
Dionne KE, Colton CK, Yarmush ML. Effect of hypoxia on insulin secretion by isolated ratand canine islets of Langerhans. Diabetes, 1993, 42, 12-21.
Metrakos P, Yuan S, Agapitos D, Rosenberg L. Paracrine signaling(duct-- > islet) in the pancreas and maintenance of islet cellmass--potential implications for islet transplantation. Transplant Proc, 1994, 26, 637-638.
Lacy PE, Finke EH. Activation of intraislet lymphoid cells causes destruction of isletcells. Am J Pathol, 1991, 138, 1183-1190.
Moore GE, Gerner RE, Franklin HA. Culture of normal human leukocytes. JAMA, 1967, 199, 519-524.
Dabbs KD, Warnock GL, Cattral MS, Rajotte RV. Reduced immunosuppression for in vitrocultured, pure canine islets transplanted from single donors. Transplant Proc, 1991, 23, 781-782.
Lakey JR, Warnock GL, Kneteman NM, Ao Z, Rajotte RV. Effects of pre-cryopreservationculture on human islet recovery and in vitro function. Transplant Proc, 1994, 26, 820.
Ohgawara H, Mochizuki N, Taira T et al . Maintenance of embedded pig pancreaticpseudo-islets in a collagen gel matrix : study of the effect of hydrocortisone, acollagenase inhibitor, and nicotinamide on collagenolysis and the morphogenesis ofpancreatic islet-cells in collagen gel matrix. In Vitro Cell Dev Biol, 1990, 26, 348-352.
Brendel MD, Kong SS, Alejandro R, Mintz DH. Improved functional survival of human isletsof Langerhans in three-dimensional matrix culture. Cell Transplantation, 1994, 3, 427-435.
Hober C, Watt PC, Brunicardi FC, Mullen Y. Characterization of a new culture method forhuman pancreatic islets. Transplant Proc, 1994, 26, 607.
Pegg DE. Viability assays for preserved cells, tissues, and organs. Cryobiology, 1989, 26, 212-231.
Andersson A, Sandler S. Viability tests of cryopreserved endocrine pancreatic cells. Cryobiology, 1983, 20, 161-168.
Rajotte RV, Stewart HL, Voss WAC, Shnitka TK, Dossetor JB. Viability studies onfrozen-thawed rat islets of Langerhans. Cryobiology, 1977, 14, 116-120.
Bank HL. Assessment of islet cell viability using fluorescent dyes. Diabetologia, 1987, 30, 812-816.
London NJM, Contractor H, Lake SP, Aucott GC, Bell PRF, James RFL. A microfluorometricviability assay for isolated human and rat islets of Langerhans. Diabetes Res, 1989, 12, 141-149.
Gray DW, Morris PJ. The use of fluorescein diacetate and ethidium bromide as a viabilitystain for isolated islets of Langerhans. Stain Technol, 1987, 62, 373-381.
Merchant FA, Aggarwal SJ, Diller KR, Bartels KA, Bovik AC. Three-dimensional distributionof damaged cells in cryopreserved pancreatic islets as determined by laser scanningconfocal microscopy. J Microsc, 1993, 169, 329-338.
Gutte N, Kuhn F, Matthes G, Georgi K, Gronau K, Braun K. The MTT-dye test for the in vitrovitality control of fresh as opposed to cryopreserved rat pancreatic islets for syngeneicintraportal islet transplantation. Z Exp Chir Transplant Kunstliche Organe, 1989, 22, 323-329.
Kuhn F, Abri O, Lohde E, Gutte N, Schulz HJ, Jahr H. In vitro rapid colorimetric assay forviability control of fresh isolated and deep-frozen human pancreatic islets. Diabetes, 1989, 38 (suppl 1), 278.
McKay DB, Karow AM. Factors to consider in the assessment of viability of cryopreservedislets of Langerhans. Cryobiology, 1983, 20, 151-160.
Lacy PE, Walker BS, Fink CJ. Perifusion of isolated rat islets in vitro :Participation of the microtubular system in the biphasic release of insulin. Diabetes, 1972, 21, 987-988.
Evans MG, Rajotte RV, Warnock GL, Kneteman NM. Viability studies on cryopreserved isolatedcanine islets of Langerhans. Transplant Proc, 1989, 21, 3368-3370.
Socci C, Davalli AM, Vignali A et al . Evidence of in vivo human islet graftfunction despite a weak response to in vitro perifusion. Transplant Proc, 1992, 24, 3056-3057.
Ricordi C, Gray DW, Hering BJ et al . Islet isolation assessment in man and largeanimals. Acta Diabetol Lat, 1990, 27, 185-195.
Ricordi C, Scharp DW, Lacy PE. Reversal of diabetes in nude mice after transplantation offresh and 7-day-cultured (24Ý C) human pancreatic islets. Transplantation, 1988, 45, 994-996.
London NJ, Thirdborough SM, Swift SM, Bell PR, James RF. The diabetic « humanreconstituted + severe combined immunodeficient (SCID-hu) mouse : a model forisogeneic, allogeneic, and xenogeneic human islet transplantation. Transplant Proc, 1991, 23, 749.
Lake SP, Chamberlain J, Bassett PD et al . Successful reversal of diabetes in nuderats by transplantation of isolated adult human islets of Langerhans. Diabetes, 1989, 38, 244-248.

Top of the page

© 1998 Elsevier Masson SAS. Tous droits réservés.
EM-CONSULTE.COM is registrered at the CNIL, déclaration n° 1286925.
As per the Law relating to information storage and personal integrity, you have the right to oppose (art 26 of that law), access (art 34 of that law) and rectify (art 36 of that law) your personal data. You may thus request that your data, should it be inaccurate, incomplete, unclear, outdated, not be used or stored, be corrected, clarified, updated or deleted.
Personal information regarding our website's visitors, including their identity, is confidential.
The owners of this website hereby guarantee to respect the legal confidentiality conditions, applicable in France, and not to disclose this data to third parties.
Article Outline
You can move this window by clicking on the headline